Search for: "Risk v. Wells Market Service, Inc." Results 841 - 860 of 1,030
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Apr 2011, 1:16 pm by Bexis
“Instructions by a manufacturer which accompany medication or use of certain marketed goods cannot be equated with publication. [read post]
22 Mar 2011, 10:57 am by Kevin LaCroix
In particular the Court reiterated its prior statement of the standard for materiality in the   Basic, Inc. v. [read post]
15 Mar 2011, 1:42 pm by WIMS
Syndicate (Click here for details) Waste Information & Management Services, Inc. [read post]
24 Feb 2011, 1:49 pm by Bexis
Alpharma USPD, Inc., 887 So.2d 881, 886 (Ala. 2004); Orr v. [read post]
11 Feb 2011, 7:51 am by Peter Rost
Peter Rost is a former Pfizer Marketing Vice President providing services as an expert witness on pharmaceutical marketing and consulting services on corporate therapeutics and ethics guidelines. [read post]
5 Feb 2011, 10:22 am by Steve Bainbridge
As long as the firm must attract inputs from nonshareholder constituencies in competitive markets, the firm similarly will have to offer those constituencies terms that compensate them for the risks they bear. [read post]
3 Feb 2011, 2:11 pm by Bexis
  FDA product approval thus should insulate defendants from allegations that their marketing of products was “outrageous. [read post]